Outsourcing Outlook March 2003

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-03-02-2003, Volume 27, Issue 3

CROs and CMOs project strong business operation in 2003, and contract sterile manufacturing companies invest millions to increase capacity.

Related Content:

OutsourcingOutsourcing OutlookPharmaceutical Technology-03-02-2003
Advent International, Warburg Pincus Complete $4.25 Billion Acquisition of Baxter’s BioPharma Solutions Business
Growing Opportunities in Outsourced Biopharma APIs
Samsung Biologics Expands Strategic Manufacturing Agreement with Bristol Myers Squibb